NCT07779928Not yet recruiting

An Innovative Proprioceptive Instrument for Upper Extremities

Development, Validation, and Clinical Application of an Innovative Proprioceptive Instrument for Upper Extremities: PropArm-PosiMoF (PropArm)

Source: ClinicalTrials.gov · Last updated 21 Aug 2026

Brief summary (registry, in English)

This study aimed to develop and validate an innovative proprioceptive assessment instrument for the upper extremities, the PropArm-PosiMoF (PropArm). This observational study was conducted in three stages. The first stage focused on the development and validation of PropArm, including test-retest reliability, concurrent validity, and convergent validity. The second stage established age norms and cut-off points in healthy adults. In the final stage, PropArm was applied to patients with proprioceptive impairments (stroke, shoulder impingement syndrome, and diabetes mellitus patients) to examine its diagnostic accuracy and clinical applicability.

Status (registry): Not yet recruiting
Study type: Observational
Enrollment: 280 (estimated)
First submitted: 17 Jul 2026
Start date: Sept 2026
Primary completion date: Dec 2027
Lead sponsor: National Cheng-Kung University Hospital
Diseases: Stroke
NCT number: NCT07779928

What you commit to

Study type: Observational
Planned participants: 280
From Sept 2026 to the primary completion date, Dec 2027
No sites listed in no country
Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

(1) Currently a student or faculty member of the Department of Occupational Therapy at National Cheng Kung University, or a staff member of the Department of Physical Medicine and Rehabilitation, National Cheng Kung University Hospital,
(1) Currently a student or faculty member of the Department of Occupational Therapy at National Cheng Kung University, or a staff member of the Department of Physical Medicine and Rehabilitation, National Cheng Kung University Hospital,
(2) Currently a student or faculty member of the Department of Occupational Therapy at National Cheng Kung University, or a staff member of the Department of Physical Medicine and Rehabilitation, National Cheng Kung University Hospital,

Other illness

(2) History of surgery on the right upper limb,
(3) Presence of neuromusculoskeletal disorders that may affect sensory or motor function of the right upper limb, such as stroke or shoulder impingement syndrome, and
(2) History of surgery on the right upper limb,
(3) Presence of neuromusculoskeletal disorders that may affect sensory or motor function of the right upper limb, such as stroke or shoulder impingement syndrome, and
(3) History of surgery on the right upper limb,
(4) Presence of neuromusculoskeletal disorders that may affect sensory or motor function of the right upper limb, such as stroke or shoulder impingement syndrome, and
Stroke:
Shoulder Impingement Syndrome:
Diabetes (DM):
(2) History of surgery on the right upper limb,
(3) Presence of other neuromusculoskeletal disorders that may affect sensory or motor function of the right upper limb, and
(4) Current skin infection, and

Other

(4) Uncorrected hearing problems, such as hearing loss.
Healthy Adults:
(4) Uncorrected hearing problems, such as hearing loss.
Healthy Older Adults:
(1) Score below the 5th percentile on the Color Trails Test-Chinese Version (CTT-C),
(5) Uncorrected hearing problems, such as hearing loss.
(1) Score below the 5th percentile on the Color Trails Test-Chinese Version (CTT-C),
(2) Upper limb still in acute pain stage,
(3) Muscle tone severe enough to affect right upper limb movement (e.g., score ≥ 1+ on the Modified Ashworth Scale),
(4) Uncorrected hearing problems, such as hearing loss.
(1) Score below the 5th percentile on the Color Trails Test-Chinese Version (CTT-C),
(2) Upper limb still in acute pain stage,
(3) Uncorrected hearing problems, such as hearing loss.
(1) Score below the 5th percentile on the Color Trails Test-Chinese Version (CTT-C),
(5) Uncorrected hearing problems, such as hearing loss.

Who the study is looking for

(1) Age between 20 and 29 years,
(2) Right-hand dominance, and
(3) Ability to understand three consecutive verbal instructions.
(1) Age between 30 to 39, 40 to 49, or 50 to 59 years,
(2) Right-hand dominance, and
(3) Ability to understand three consecutive verbal instructions.
(1) Age between 60 to 69, 70 to 79, or 80 to 89 years,
(2) Right-hand dominance, and
(3) Ability to understand three consecutive verbal instructions.
(1) Age between 20 and 89 years,
(2) Right-hemispheric hemorrhagic or ischemic stroke with lesions involving proprioceptive pathways or the primary somatosensory cortex, potentially resulting in difficulties with body position, movement, or force perception, or with fine tactile perception (e.g., localization, two-point discrimination, object recognition),
(3) Right-hand dominance, and
(4) Ability to understand three consecutive verbal instructions.
(1) Age between 20 and 89 years,
(2) Diagnosis of shoulder impingement syndrome in the right upper limb,
(3) Right-hand dominance, and
(4) Ability to understand three consecutive verbal instructions.
(1) Age between 20 and 89 years,
(2) Diagnosis of diabetes mellitus by a specialist physician, based on one of the following:
- Fasting plasma glucose (FPG) ≥ 126 mg/dL or 7.0 mmol/L;
- Hemoglobin A1C (HbA1c) ≥ 6.5%;
- Plasma glucose ≥ 200 mg/dL or 11.1 mmol/L at 2 hours during an oral glucose tolerance test (OGTT);
- Presence of hyperglycemia symptoms (polyphagia, polyuria, polydipsia, and unexplained weight loss) with a random plasma glucose ≥ 200 mg/dL.
- Diagnosis of diabetes is confirmed if any two of items (a-c) are met, or if any one of them remains positive on repeat testing; fulfillment of item (d) alone is also sufficient for diagnosis.
(3) Right-hand dominance, and
(4) Ability to understand three consecutive verbal instructions.

Criteria the registry did not label

Healthy Young Adults:

Age in the registry: 20 years to 89 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.